Risk Factors Associated With New-Onset Myocardial Perfusion Abnormalities in Kidney Transplant Candidates

• Published in: The American journal of cardiology 2022-07, Vol.174, p.84-88
• Main Authors: Godwin, Lehman, Zheng, Ziduo, Kundu, Suprateek, Cousins, Ryan, Mullinax, Billy Joe, Ko, Yi-An, Little, Kendra, Smith, Andrew, Quyyumi, Arshed, Goyal, Abhinav, Pearson, Thomas, Moncayo, Valeria, Mitchell, Adam J.
• Format: Article
• Language: English
• Subjects: Abnormalities; Angina pectoris; Cardiovascular disease; Coronary artery; Coronary artery disease; Coronary vessels; Defects; Diabetes; Ejection fraction; End-stage renal disease; Gender; Heart diseases; Hospitals; Hypertension; Ischemia; Kidney diseases; Kidney transplantation; Kidney transplants; Males; Medical imaging; Mortality; Myocardial infarction; Patients; Perfusion; Risk analysis; Risk factors; Surveillance; Tomography; Vascular diseases; Vein & artery diseases
• ISSN: 0002-9149; 1879-1913
• DOI: 10.1016/j.amjcard.2022.03.030

The optimal coronary artery disease surveillance strategy for end-stage renal disease patients being evaluated for kidney transplantation is unknown. It is unclear what risk factors are associated with the development of new-onset perfusion abnormalities on serial myocardial perfusion imaging. Potential kidney transplant recipients who underwent 2 myocardial perfusion imaging studies at Emory University Hospital between January 2010 and December 2019 were identified. We assessed the frequency of development of any new perfusion defect and development of moderate to severe ischemia (reversible perfusion defect >10%) on serial imaging. Finally, we identified the clinical and imaging factors associated with new perfusion defects and explored the association between new perfusion defects and all-cause mortality. History of myocardial infarction (MI) and peripheral artery disease was associated with an increased risk of developing a new perfusion defect. History of MI was also associated with the risk of developing moderate-severe ischemia. Female patients were less likely to develop new perfusion defects or moderate-severe ischemia. There was no association between either outcome and all-cause mortality. In conclusion, a history of MI, peripheral artery disease, and male gender are risk factors for developing new perfusion defects, although only the history of MI and male gender predict moderate to severe ischemia. Interval development of any abnormal perfusion is not associated with increased mortality.